Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lie

Showing results (281-290 of 415) with videos related to

Pageof 42
Sort By:
The American Journal of Cardiology|August 1, 1992
Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathyS A van den Broek, D J van Veldhuisen, P A de Graeff, et al.
Heart (British Cardiac Society)|April 30, 1999
Two hour ambulation after coronary angioplasty and stenting with 6 F guiding catheters and low dose heparinK T Koch, J J Piek, R J de Winter, et al.
Journal of Cardiovascular Pharmacology|July 1, 1994
Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captoprilW H van Gilst, D J van Veldhuisen, H Hegeman, et al.
European Heart Journal|June 1, 1988
Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimensH J Crijns, L M van Wijk, W H van Gilst, et al.
Journal of Cardiac Failure|December 1, 1995
Effects of lisinopril in patients with heart failure and chronic atrial fibrillationM P Van Den Berg, H J Crijns, D J Van Veldhuisen, et al.
The American Journal of Cardiology|October 15, 1992
Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmiasA C Wiesfeld, H J Crijns, T J Tobé, et al.
Journal of Human Hypertension|March 1, 1995
Hypertension and left ventricular hypertrophy in black peopleA J van Boven, H P de Haan, A E Saleh, et al.
American Heart Journal|December 1, 1988
Value of New York Heart Association classification, radionuclide ventriculography, and cardiopulmonary exercise tests for selection of patients for congestive heart failure studiesP H Dunselman, C E Kuntze, A van Bruggen, et al.
The American Journal of Cardiology|March 1, 1996
Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectorisR W Hautvast, P K Blanksma, M J DeJongste, et al.
The American Journal of Cardiology|May 1, 1996
Prediction of the left ventricular mass from the electrocardiogram in systemic hypertensionS O de Vries, W F Heesen, F W Beltman, et al.
Pageof 42

Showing results (281-290 of 415) with videos related to

Sort By:
Pageof 42
The American Journal of Cardiology|August 1, 1992
Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathyS A van den Broek, D J van Veldhuisen, P A de Graeff, et al.
Heart (British Cardiac Society)|April 30, 1999
Two hour ambulation after coronary angioplasty and stenting with 6 F guiding catheters and low dose heparinK T Koch, J J Piek, R J de Winter, et al.
Journal of Cardiovascular Pharmacology|July 1, 1994
Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captoprilW H van Gilst, D J van Veldhuisen, H Hegeman, et al.
European Heart Journal|June 1, 1988
Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimensH J Crijns, L M van Wijk, W H van Gilst, et al.
Journal of Cardiac Failure|December 1, 1995
Effects of lisinopril in patients with heart failure and chronic atrial fibrillationM P Van Den Berg, H J Crijns, D J Van Veldhuisen, et al.
The American Journal of Cardiology|October 15, 1992
Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmiasA C Wiesfeld, H J Crijns, T J Tobé, et al.
Journal of Human Hypertension|March 1, 1995
Hypertension and left ventricular hypertrophy in black peopleA J van Boven, H P de Haan, A E Saleh, et al.
American Heart Journal|December 1, 1988
Value of New York Heart Association classification, radionuclide ventriculography, and cardiopulmonary exercise tests for selection of patients for congestive heart failure studiesP H Dunselman, C E Kuntze, A van Bruggen, et al.
The American Journal of Cardiology|March 1, 1996
Effect of spinal cord stimulation on myocardial blood flow assessed by positron emission tomography in patients with refractory angina pectorisR W Hautvast, P K Blanksma, M J DeJongste, et al.
The American Journal of Cardiology|May 1, 1996
Prediction of the left ventricular mass from the electrocardiogram in systemic hypertensionS O de Vries, W F Heesen, F W Beltman, et al.
Pageof 42